A Polish study performed WES on 73 patients clinically diagnosed with LGMD, identifying pathogenic DYSF variants causing LGMD type 2B or a dysferlinopathy subtype of LGMD in 6 cases (8%). The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.